The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies

Documenti analoghi

• Current clinical findings of acute neurological syndromes after SARS‐CoV‐2 infection
  di: Minjin Wang, et al.
  Pubblicazione: (2024)
• Combining Intramuscular and Intranasal Immunization With the MF59‐Adjuvanted Respiratory Syncytial Virus Pre‐Fusion Protein Subunit Vaccine Induces Potent Humoral and Cellular Immune Responses in Mice
  di: Jie Shi, et al.
  Pubblicazione: (2025)
• Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
  di: Ying Lu, et al.
  Pubblicazione: (2025)
• Optimization and validation of a virus‐like particle pseudotyped virus neutralization assay for SARS‐CoV‐2
  di: Shuo Liu, et al.
  Pubblicazione: (2024)
• Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP
  di: Tingfu Du, et al.
  Pubblicazione: (2026)